The pattern no single source sees

Search

Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.

Company or person18

Krystal Biotech, Inc.

Company

13 records in the corpus

NKGen Biotech, Inc.

Company

1 records in the corpus

Edesa Biotech, Inc.

Company

12 records in the corpus

XBiotech Inc.

Company

4 records in the corpus

Fortress Biotech, Inc.

Company

5 records in the corpus

Moleculin Biotech, Inc.

Company

23 records in the corpus

PharmaCyte Biotech, Inc.

Company

1 records in the corpus

ONCOLYTICS BIOTECH INC

Company

10 records in the corpus

GOLDENWELL BIOTECH, INC.

Company

3 records in the corpus

Vir Biotechnology, Inc.

Company

9 records in the corpus

MAIA Biotechnology, Inc.

Company

5 records in the corpus

PUMA BIOTECHNOLOGY, INC.

Company

2 records in the corpus

Sana Biotechnology, Inc.

Company

5 records in the corpus

KALA BIO, Inc.

Company

7 records in the corpus

CitroTech Inc.

Company

7 records in the corpus

Korro Bio, Inc.

Company

12 records in the corpus

Nautilus Biotechnology, Inc.

Company

6 records in the corpus

BiomX Inc.

Company

23 records in the corpus

Primary record12

Krystal Biotech, Inc. filed 8-K

Item 2.02 Results of Operations and Financial Condition On November 2, 2026 , Krystal Biotech, Inc., a Delaware corporation (the “Company”), announced its financial results for the quarter ending September 30, 2026. A co

02 Nov 2026 · sec daily index

Krystal Biotech, Inc. filed SCHEDULE 13G/A

0002100121-26-001077.txt : 20261030 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0002100121 XXXXXXXX LIVE 1 Common Stock 09/30/2026 0001711279 Krystal Biotech Inc 501147102 2100 Wharton Street Suite 701 Pittsbur

30 Oct 2026 · sec daily index

BlackRock, Inc. filed SCHEDULE 13G/A

0002012383-26-003918.txt : 20261027 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0002012383 XXXXXXXX LIVE 5 Common Stock 09/30/2026 0001711279 KRYSTAL BIOTECH INC 501147102 2100 WHARTON STREET SUITE 701 PITTSBUR

27 Oct 2026 · sec daily index

Krystal Biotech, Inc. filed 8-K

Item 7.01 Regulation FD Disclosure. On October 15, 2026, Krystal Biotech, Inc. (the Company ) issued a press release announcing clinical data from its Gorlin Syndrome Pilot Study evaluating KB113 for the treatment of bas

15 Oct 2026 · sec daily index

Krystal Biotech, Inc. filed 4

SEC form 4 filed by Krystal Biotech, Inc. (CIK 1711279) on 2026-09-16.

16 Sep 2026 · sec daily index

Krystal Biotech, Inc. filed 4

SEC form 4 filed by Krystal Biotech, Inc. (CIK 1711279) on 2026-09-16.

16 Sep 2026 · sec daily index

Krystal Biotech, Inc. filed 4

SEC form 4 filed by Krystal Biotech, Inc. (CIK 1711279) on 2026-09-16.

16 Sep 2026 · sec daily index

Krystal Biotech, Inc. filed 4

SEC form 4 filed by Krystal Biotech, Inc. (CIK 1711279) on 2026-09-16.

16 Sep 2026 · sec daily index

Krystal Biotech, Inc. filed 4

SEC form 4 filed by Krystal Biotech, Inc. (CIK 1711279) on 2026-09-16.

16 Sep 2026 · sec daily index

Krystal Biotech, Inc. filed 4

SEC form 4 filed by Krystal Biotech, Inc. (CIK 1711279) on 2026-09-16.

16 Sep 2026 · sec daily index

Krystal Biotech, Inc. filed 4

SEC form 4 filed by Krystal Biotech, Inc. (CIK 1711279) on 2026-09-04.

04 Sep 2026 · sec daily index

Krystal Biotech, Inc. filed 4

SEC form 4 filed by Krystal Biotech, Inc. (CIK 1711279) on 2026-09-04.

04 Sep 2026 · sec daily index